From: Genome-wide approaches for identifying genetic risk factors for osteoporosis
Genes | Full names | Refs |
---|---|---|
RANK/RANKL/OPG pathway | Â | Â |
TNFSF11 | TNF (ligand) superfamily, member 11 (RANKL) | |
TNFRSF11A | TNF receptor 11a, NF-κB activator (RANK) | |
TNFRSF11B | TNF receptor 11b (OPG) | |
TNF-R1/TRAIL signaling pathway b | Â | Â |
CFLAR | CASP8 and FADD-like apoptosis regulator | [37] |
NFKB1 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | [37] |
TNFSF10 | TNF (ligand) superfamily, member 10 | [37] |
TNFRSF1B, TNFRSF10B | TNF receptors | [37] |
TRAF3 | TNF receptor-associated factor 3 | [37] |
Wnt signaling pathway | Â | Â |
CTNNB1 | Î’-catenin | |
DKK1 | Dickkopf-related protein 1 | |
LRP4, LRP5 | Lipoprotein receptor related peptides | |
RSPO3 | R-spondin 3 | [25] |
SOST | Sclerostin | |
WNT4, WNT15 | Wnt proteins | [61] |
Autophagy regulation pathway | Â | Â |
ATG5, ATG7, ATG12 | Autophagy-related proteins | [36] |
IFNA4, IFNA5, IFNA7, IFNA8, IFNA13, IFNA14, IFNA16, IFNA17, IFNA21, | Interferon α proteins | [36] |
PIK3C3 | Phosphatidylinositol 3-kinase catalytic subunit type 3 | [36] |
Other pathways | Â | Â |
ALDH7A1 | Aldehyde dehydrogenase 7 family, member A1 | [33] |
ARHGAP1 | Rho GTPase activating protein 1 | |
COL1A1 | Collagen, type I, α1 | |
DCDC5 | Doublecortin domain containing 5 | |
ESR1 | Estrogen receptor 1 | |
FLJ42280 | Putative uncharacterized protein FLJ42280 | |
FOXL1 | Forkhead box L1 | |
GALNT3 | UDP-N-acetyl-a-d-galactosamine: polypeptide N-acetylgalactosaminyltransferase 3 | [25] |
HDAC5 | Histone deacetylase 5 | |
JAG1 | Jagged 1 (Notch ligand) | [46] |
MEF2C | Myocyte enhancer factor 2C | [26] |
MEPE | Matrix extracellular phosphoglycoprotein | |
STARD3NL | STARD3 amino-terminal like protein | |
SOX6 | Sex-determining region Y-box 6 | |
SP7 | Sp7 transcription factor | [26] |
SPTBN1 | Spectrin, β, non-erythrocytic 1 | |
TGFBR1 | TGF, β receptor I | [66] |